Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,801 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aryl piperazine melanocortin MC4 receptor agonists.
Dyck B, Parker J, Phillips T, Carter L, Murphy B, Summers R, Hermann J, Baker T, Cismowski M, Saunders J, Goodfellow V. Dyck B, et al. Among authors: parker j. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3793-6. doi: 10.1016/s0960-894x(03)00796-0. Bioorg Med Chem Lett. 2003. PMID: 14552781
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
Pontillo J, Tran JA, Arellano M, Fleck BA, Huntley R, Marinkovic D, Lanier M, Nelson J, Parker J, Saunders J, Tucci FC, Jiang W, Chen CW, White NS, Foster AC, Chen C. Pontillo J, et al. Among authors: parker j. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4417-23. doi: 10.1016/j.bmcl.2004.06.059. Bioorg Med Chem Lett. 2004. PMID: 15357964
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines.
Tucci FC, White NS, Markison S, Joppa M, Tran JA, Fleck BA, Madan A, Dyck BP, Parker J, Pontillo J, Arellano LM, Marinkovic D, Jiang W, Chen CW, Gogas KR, Goodfellow VS, Saunders J, Foster AC, Chen C. Tucci FC, et al. Among authors: parker j. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4389-95. doi: 10.1016/j.bmcl.2005.06.071. Bioorg Med Chem Lett. 2005. PMID: 16098742
A new approach for assessing the radioecological risk associated with the legacy discharge of oil derived natural radioactivity in the UK North Sea.
Dal Molin F, Hunt D, Dewar A, Lozach S, Phillips C, Thomas B, Warford L, Parker JE, Walker J, Chocholek M, Paterson DM, Woodward-Rowe H, Hicks N. Dal Molin F, et al. Among authors: parker je. Mar Pollut Bull. 2025 Jan 23;212:117585. doi: 10.1016/j.marpolbul.2025.117585. Online ahead of print. Mar Pollut Bull. 2025. PMID: 39855067
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers.
Lynce F, Martínez-Sáez O, Walbaum B, Brasó-Maristany F, Waks AG, Villagrasa P, Villacampa Javierre G, Sanfeliu E, Galván P, Paré L, Anderson LM, Perou CM, Parker JS, Vivancos A, DiLullo MK, Pernas S, Winer EP, Overmoyer B, Mittendorf EA, Bueno-Muiño C, Martín M, Prat A, Tolaney SM. Lynce F, et al. Among authors: parker js. ESMO Open. 2025 Jan 17;10(2):104100. doi: 10.1016/j.esmoop.2024.104100. Online ahead of print. ESMO Open. 2025. PMID: 39826476 Free article.
5,801 results